'lizbeth
09-21-2013, 11:59 AM
322 study sites - internationally (outside of the US)
A Study of Pertuzumab in Combination With Herceptin (Trastuzumab) and A Taxane in First-Line Treatment in Patients With HER2-Positive Advanced Breast Cancer (PERUSE)
ClinicalTrials.gov Identifier:
NCT01572038
http://www.clinicaltrials.gov/ct2/show/study/NCT01572038?term=Her2+Metastatic+Breast&recr=Recruiting&phase=2&rank=20&show_locs=Y#locn
A Study of Pertuzumab in Combination With Herceptin (Trastuzumab) and A Taxane in First-Line Treatment in Patients With HER2-Positive Advanced Breast Cancer (PERUSE)
ClinicalTrials.gov Identifier:
NCT01572038
http://www.clinicaltrials.gov/ct2/show/study/NCT01572038?term=Her2+Metastatic+Breast&recr=Recruiting&phase=2&rank=20&show_locs=Y#locn